文献速递瓣膜病与结构性心脏病

1990-2017年全球、区域及国家钙化性主动脉瓣与退行性二尖瓣疾病负担

Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
PubMed 文献 · Circulation · 2020-03-29

基于全球疾病负担研究2017框架,利用生命登记、流行病学调查和医院管理数据估算195个国家1990-2017年非风湿性瓣膜病负担。1990-2017年两者DALY分别增加101%和35%,钙化性主动脉瓣病年龄标化DALY率在高收入国家最高。

要点

  • 钙化性主动脉瓣病和退行性二尖瓣病是老年人重要疾病负担,DALY持续增长。
  • 钙化性主动脉瓣病年龄标化DALY率在高收入国家最高,存在显著地理差异。

核心结论

  • 钙化性主动脉瓣病和退行性二尖瓣病是老年人重要疾病负担,需明确可干预危险因素并改善瓣膜干预可及性。
  • 1990-2017年钙化性主动脉瓣病和退行性二尖瓣病DALY分别增加101%和35%。

研究设计与样本

  • 全球疾病负担研究2017建模框架,利用生命登记、流行病学调查和医院管理数据估算195个国家1990-2017年负担。
  • 采用地理空间统计方法估算所有国家疾病负担,并考虑疾病严重程度及瓣膜修复或置换手术可及性。

主要发现

  • 1990-2017年钙化性主动脉瓣病DALY增加101%(95%UI 79%-117%),退行性二尖瓣病DALY增加35%(95%UI 23%-47%)。
  • 钙化性主动脉瓣病年龄标化DALY率在高收入国家最高,患病率、死亡率及总体负担存在显著地理差异。

临床怎么用

  • 关注老年人钙化性主动脉瓣病和退行性二尖瓣病的疾病负担,结合地理差异评估区域防治需求。
  • 改善瓣膜修复或置换手术可及性,并探索可干预危险因素以降低疾病负担。

局限性

  • 非风湿性瓣膜病数据在全球部分地区(如撒哈拉以南非洲和南亚)极为有限,依赖地理空间统计方法估算。
  • 结果基于模型估算,并考虑了疾病严重程度及瓣膜干预可及性的估计水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nonrheumatic valvular diseases are common; however, no studies have estimated their global or national burden. As part of the Global Burden of Disease Study 2017, mortality, prevalence, and disability-adjusted life-years (DALYs) for calcific aortic valve disease (CAVD), degenerative mitral valve disease, and other nonrheumatic valvular diseases were estimated for 195 countries and territories from 1990 to 2017. METHODS: Vital registration data, epidemiologic survey data, and administrative hospital data were used to estimate disease burden using the Global Burden of Disease Study modeling framework, which ensures comparability across locations. Geospatial statistical methods were used to estimate disease for all countries, because data on nonrheumatic valvular diseases are extremely limited for some regions of the world, such as Sub-Saharan Africa and South Asia. Results accounted for estimated level of disease severity as well as the estimated availability of valve repair or replacement procedures. DALYs and other measures of health-related burden were generated for both sexes and each 5-year age group, location, and year from 1990 to 2017. RESULTS: Globally, CAVD and degenerative mitral valve disease caused 102 700 (95% uncertainty interval [UI], 82 700-107 900) and 35 700 (95% UI, 30 500-42 500) deaths, and 12.6 million (95% UI, 11.4 million-13.8 million) and 18.1 million (95% UI, 17.6 million-18.6 million) prevalent cases existed in 2017, respectively. A total of 2.5 million (95% UI, 2.3 million-2.8 million) DALYs were estimated as caused by nonrheumatic valvular diseases globally, representing 0.10% (95% UI, 0.09%-0.11%) of total lost health from all diseases in 2017. The number of DALYs increased for CAVD and degenerative mitral valve disease between 1990 and 2017 by 101% (95% UI, 79%-117%) and 35% (95% UI, 23%-47%), respectively. There is significant geographic variation in the prevalence, mortality rate, and overall burden of these diseases, with highest age-standardized DALY rates of CAVD estimated for high-income countries. CONCLUSIONS: These global and national estimates demonstrate that CAVD and degenerative mitral valve disease are important causes of disease burden among older adults. Efforts to clarify modifiable risk factors and improve access to valve interventions are necessary if progress is to be made toward reducing, and eventually eliminating, the burden of these highly treatable diseases.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Yadgir S, Johnson CO, Aboyans V, et al. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017. Circulation. 2020. PMID: 32223336. doi:10.1161/CIRCULATIONAHA.119.043391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。